Pharmacodynamic Impact of Carboxylesterase 1 Gene Variants in Patients with Congestive Heart Failure Treated with Angiotensin-Converting Enzyme Inhibitors
about
Pharmacodynamic Impact of Carboxylesterase 1 Gene Variants in Patients with Congestive Heart Failure Treated with Angiotensin-Converting Enzyme Inhibitors
description
2016 nî lūn-bûn
@nan
2016 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Pharmacodynamic Impact of Carb ...... n-Converting Enzyme Inhibitors
@ast
Pharmacodynamic Impact of Carb ...... n-Converting Enzyme Inhibitors
@en
Pharmacodynamic Impact of Carb ...... n-Converting Enzyme Inhibitors
@nl
type
label
Pharmacodynamic Impact of Carb ...... n-Converting Enzyme Inhibitors
@ast
Pharmacodynamic Impact of Carb ...... n-Converting Enzyme Inhibitors
@en
Pharmacodynamic Impact of Carb ...... n-Converting Enzyme Inhibitors
@nl
prefLabel
Pharmacodynamic Impact of Carb ...... n-Converting Enzyme Inhibitors
@ast
Pharmacodynamic Impact of Carb ...... n-Converting Enzyme Inhibitors
@en
Pharmacodynamic Impact of Carb ...... n-Converting Enzyme Inhibitors
@nl
P2093
P2860
P50
P3181
P1433
P1476
Pharmacodynamic Impact of Carb ...... n-Converting Enzyme Inhibitors
@en
P2093
Ditte Bjerre
Henrik B Rasmussen
INDICES Consortium
Laura Ferrero
Martin Egfjord
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0163341
P407
P577
2016-09-23T00:00:00Z